key: cord-0794262-zbk7smm3
authors: Yang, Jun; Hu, Jiahui; Zhu, Chunyan
title: Obesity aggravates COVID‐19: a systematic review and meta‐analysis
date: 2020-06-30
journal: J Med Virol
DOI: 10.1002/jmv.26237
sha: f78cc8b1ed4fb18fc99dcc96b6cbc4661eb8c43b
doc_id: 794262
cord_uid: zbk7smm3

OBJECTIVE: Obesity and COVID‐19 are both world epidemics now. There may be some potential relationships between them, but we knew little. This work was to explore the relationship through literature searching, systematic review, and meta‐analysis. METHODS: Pubmed, Embase, WOS, Cochrane, CNKI, Wanfang, and Sinomed databases were searched to collect the literature concerning obesity and COVID‐19. Systematic review and meta‐analysis were conducted after literature screening, quality assessment, and data extraction. RESULTS: 180 articles were initially searched after duplicate removal and 9 were finally included in our analysis. Results show that severe COVID‐19 patients have higher BMI than non‐severe ones(WMD =2.67, 95%CI[1.52‐3.82]); COVID‐19 patients with obesity were more severe and have a worse outcome than those without(OR=2.31, 95%CI[1.3‐4.12]). CONCLUSION: Obesity may aggravate COVID‐19. This article is protected by copyright. All rights reserved.

heterogeneity would be considered large. Then the random effect model would be used to combine the numerical values of each study. Sensitivity analysis will be used to identify the source of heterogeneity. Otherwise, the fixed effect model would be used. Funnel plots would be drawn to evaluate the publication bias of included literature. All p values were bilateral, and p < 0.05 was considered significant.

Results:

We found 180 articles without duplication for eligibility and included 9 for systematic review and meta-analysis after screening. [10] [11] [12] [13] [14] [15] [16] [17] [18] . Among those included, 6 [10] [11] [12] 15, 16, 18] were retrospective case-control studies and 4 [10, 13, 14, 17] were retrospective cohort studies. It was worth noting that one of the papers contain two research approaches and involved in both types of integrated analysis [10] . The quality of study design among the selected studies was median, with a median quality score of 6. Seven of the nine studies were conducted in China [11, 12, [14] [15] [16] [17] [18] , while one in France [10] and one in the USA [13] . They were published between 2020 February and April. A total of 4444 participants were enrolled in our study. Five of the nine studies had fewer than 100 subjects [11] [12] [13] 17, 18] . Two studies, one from the USA [13] and the other from France [10] , have used 30kg/m 2 as diagnostic thresholds for obesity, while the remaining two studies from China have taken 24kg/m 2 [17] and 25kg/m 2 [14] , respectively. Most of the studies chose Accepted Article patients as subjects, while two identified those patients complicated with cardiovascular disease [15] and metabolic associated fatty liver disease [14] respectively. The age has differed among the studies, ranging from younger than 40 years old to older than 60 years old. Detailed characteristics are presented in Table 1 .

Six studies have compared BMI in severe and non-severe COVID-19 patients. We integrated these results and found a moderate heterogeneity among them(I 2 =63.8%, p=0.017). Then we chose random effects model(REM) to combine the effect quantity. The results show that severe patients have a higher BMI, with a pooled WMD of 2.67(95%CI, 1.52-3.82), than non-severe ones( Figure 2A ).

Considering the heterogeneity among 6 included studies, we carried out a sensitivity analysis to verify its stability. The results show that no study has changed the overall heterogeneity, which is stable( Figure 2B ).

As sample size and disease severity vary among these studies, we carried out subgroup analysis to identify possible disturbances. The results indicate that sample size and disease severity seem to play little role in the overall heterogeneity( Table 2) .

As the number of included papers in this part was less than 10 articles, we didn't carry out meta-regression analysis. This article is protected by copyright. All rights reserved.

conditions once infected with COVID-19. These results indicate that obesity may exacerbate COVID-19.

Lighter J and colleagues have found that COVID-19 patients younger than 60 were more likely to receive hospital or ICU admission when with obesity.

Simonnet A and colleagues [10] have found the proportion of COVID-19 patients requiring mechanical ventilation to increase with BMI. As we were writing this article, Caussy C and colleagues [19] had observed the same phenomenon as Simonnet A. The results above add to our confidence in the role that obesity may play in COVID-19 progression.

Obesity could lead to severe conditions of COVID-19 in several possible ways, some of which have been published by scholars: 1. Obesity and subsequent metabolic syndrome could cause damage to organs, which may turn into function failure when faced with such stress [20, 21] ; 2. Obesity was accompanied by increased expression of ACE2, which would bind to the virus S protein firmly and make adipose tissue a portal for virus invasion [22] , make lung and heart vulnerable to virus attack [23] ; 3. Obesity was accompanied by a state of overactivated inflammation and immune response, which may induce the excessive inflammatory response and immune exhaustion in COVID-19; 4. Obese patients have increased abdominal pressure, limited chest expansion and movement, and insufficient respiratory compensatory function. In the case of lung infection, they are more likely to develop into respiratory failure [24] . This article is protected by copyright. All rights reserved. 

United States: 2020

Metformin and COVID-19: A novel deal of an Old Drug

Analysis of clinical characteristics of 49 patients with coronavirus disease 2019 in Jiangxi

Extrapulmonary organ damage and clinical significance in patients with coronavirus disease

Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission

Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV

This article is protected by copyright. All rights reserved

Accepted Article